188 filings
Page 6 of 10
8-K
s4z dmmfdru9uzttvxg
14 Nov 07
Mylan Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock
12:00am
8-K
1dlxf47
13 Nov 07
Other Events
12:00am
8-K
bgg tpopujvgmy
7 Nov 07
Other Events
12:00am
8-K/A
64meoi
1 Nov 07
Mylan Completes Acquisition of Generics Business of Merck KGaA
12:00am
8-K
rajeoa
1 Nov 07
Mylan Reports Adjusted Diluted Cash EPS of $0.31 Reports Highest Ever Diluted EPS Through The First Two Quarters
12:00am
8-K
j1zphxs
5 Oct 07
Mylan Appoints Heather Bresch as Chief Operating Officer
12:00am
8-K
jvl08m0dyh 731
1 Aug 07
Departure of Directors or Principal Officers
12:00am
8-K
u886nzi24a1rxu7
26 Jul 07
Results of Operations and Financial Condition
12:00am
8-K
sr3n12yn
24 May 07
Mylan Reports Fourth Quarter & Fiscal 2007 Adjusted Diluted EPS of $0.47 & $1.65 Excluding any Contribution from Amlodipine
12:00am
8-K
ohvl7f7rqm
17 May 07
Mylan Laboratories to Acquire Generics Business of Merck KGaA
12:00am
8-K
ajhjo2a9 fj
30 Mar 07
Entry into a Material Definitive Agreement
12:00am
8-K
8lerqb1ei7 ek51
27 Mar 07
United States District Court for the District of Columbia
12:00am
8-K
dhc9c9y3j82mi1e
7 Mar 07
Entry into a Material Definitive Agreement
12:00am
8-K
x7w9a
28 Feb 07
Other Events
12:00am
8-K/A
6myqv rtnka
20 Feb 07
Mylan Laboratories Completes Matrix Laboratories Transaction
12:00am
8-K
v1p67jf3o9oemrtmzlk2
20 Feb 07
Unregistered Sales of Equity Securities
12:00am
8-K
a5m6ng
1 Feb 07
Results of Operations and Financial Condition
12:00am
8-K
7qhi 8ll5ivfn
1 Feb 07
Dr. John P. O’Donnell Will Retire as Chief Scientific Officer and Continue on with Mylan as Strategic Scientific Advisor in the Office of the CEO
12:00am
8-K
ypwps51ukwvz9
10 Jan 07
Mylan Laboratories Completes Matrix Laboratories Transaction
12:00am
8-K
c70c546xgr4xog08jz7g
21 Dec 06
Mylan Laboratories Announces Closing of Public Offer to Acquire 20% of Matrix Laboratories Limited
12:00am